ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks [Yahoo! Finance]
Oramed Pharmaceuticals Inc. (ORMP)
Last oramed pharmaceuticals inc. earnings: 4/6 04:46 pm
Check Earnings Report
US:NASDAQ Investor Relations:
oramed.com/investors
Company Research
Source: Yahoo! Finance
Oramed Pharmaceuticals (NASDAQ:ORMP) has named its former Chief Financial Officer to the CFO position again. In June 2024, the company named Avraham Gabay as CFO, Secretary and Treasurer to replace former CFO David Silberman. Mr. Silberman had announced his intention to resign effective July 12, 2024, citing personal reasons. Mr. Gabay served as CFO at Oravax Inc., a 63% owned Oramed subsidiary, from 2021 until 2023 and as ORMP's CFO from 2019 until 2021. He also has extensive outside public company and accounting experience, having been interim CFO at BiomX Inc. (NYSE American: PHGE) from 2023 until 2024 and VP Finance at Orcam Technologies Ltd. prior to that from 2015 to 2019, among other senior roles. He resumes his position as CFO at a time when Oramed believes it has the financial flexibility and balance sheet to continue development activities and initiate a share buyback. In fact, at the end of 2Q24, Oramed had about $153 million in cash and equivalents to advance its develo
Show less
Read more
Impact Snapshot
Event Time:
ORMP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORMP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORMP alerts
High impacting Oramed Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
ORMP
News
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) had its "neutral" rating re-affirmed by analysts at HC Wainwright.MarketBeat
- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
ORMP
Earnings
- 8/14/24 - Beat
ORMP
Analyst Actions
- 9/9/24 - HC Wainwright
ORMP
Sec Filings
- 9/26/24 - Form 8-K
- 9/23/24 - Form 8-K
- 9/16/24 - Form SC
- ORMP's page on the SEC website